Junyuan Jerry Wang

Insider Reports History

Entity
Individual
Location
C/O Nuvation Bio Inc., 1500 Broadway, Suite 1401, New York, NY
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Junyuan Jerry Wang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Class A Common Stock 3.87M $11.2M $2.89 Nov 11, 2024 Direct
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Class A Common Stock 2.25M $6.49M $2.89 Nov 11, 2024 By LLC
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Stock Option (Right to Buy) 388K Apr 9, 2024 Direct
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Warrants (Right to Buy) 86.5K Sep 3, 2024 Direct
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Warrants (Right to Buy) 57.6K Sep 3, 2024 By LLC
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Series A Preferred Stock 0 Sep 4, 2024 By LLC
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Series A Preferred Stock 0 Sep 4, 2024 Direct

Insider Reports Filed by Junyuan Jerry Wang

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NUVB Nuvation Bio Inc. Nov 11, 2024 1 -$163K 4 Nov 13, 2024 CEO, ANHEART THERAPEUTICS LTD., Director
NUVB Nuvation Bio Inc. Sep 3, 2024 8 $0 4 Sep 5, 2024 CEO, ANHEART THERAPEUTICS LTD., Director
NUVB Nuvation Bio Inc. Apr 9, 2024 4 $0 4 Apr 11, 2024 CEO, ANHEART THERAPEUTICS LTD., Director
NUVB Nuvation Bio Inc. Apr 9, 2024 0 $0 3 Apr 11, 2024 CEO, ANHEART THERAPEUTICS LTD., Director